Decreased FSP1 expression under chronic hypoxia sensitizes human macrophages towards ferroptosis
- 1Institute of Biochemistry I, Faculty of Medicine, Goethe University Frankfurt, Frankfurt, Germany
- 2Institute of Biochemistry I, Faculty of Medicine, Goethe University Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute, Goethe University Frankfurt, Germany
- 3Institute of Biochemistry I, Faculty of Medicine, Goethe University Frankfurt, Frankfurt, Germany; Corresponding author. Goethe University Frankfurt Faculty of Medicine Institute of Biochemistry I, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
Abstract
Ferroptosis, an iron-dependent cell death, emerged as a new therapeutic approach to treat diseases such as cancer or diabetes. Several pathological conditions are characterized by the appearance of chronic hypoxia, which is known to attract immune cells, especially monocytes and macrophages. Therefore, we investigated how chronic hypoxia affects ferroptosis in primary human macrophages and THP-1 cells. Chronic but not acute hypoxia sensitized cells towards ferroptosis, in line with elevated cellular as well as mitochondrial lipid peroxides, and mitochondrial ROS. Time kinetics revealed an earlier increase in lipid peroxidation under chronic hypoxia compared to normoxia, which was followed by mitochondrial lipid peroxidation and mitochondrial ROS. Mechanistically, and in contrast to normoxia and/or acute hypoxia, chronic hypoxia diminished nuclear abundance and activity of the antioxidant transcription factor NRF2. Consequently, NRF2 target gene expression, including ferroptosis suppressor protein 1 (FSP1), decreased. Inhibition or knockdown of FSP1 mimicked the ferroptosis-sensitizing effect of chronic hypoxia. To causatively link decreased NRF2 activity to increased ferroptosis under hypoxia, we inhibited KEAP1, which preserved NRF2 activity, increased FSP1 expression, and decreased ferroptosis. Our data provides novel insights into NRF2 regulation under chronic hypoxia linked to FSP1 expression and ferroptosis sensitivity of primary human macrophages.
Related
- CircAbcc1-encoded ABCC1-677aa modulates DLX1 to suppress ferroptosis in chronic cerebral ischemia
- Transcription factor FOXA1 suppresses ferroptosis of cervical cancer cells by upregulating SLC7A11 expression
- METTL3-mediated m⁶A modification targets the regulation of PCBP1 expression, thereby modulating GPX4 levels and intracellular Fe²⁺ homeostasis to influence ferroptosis and contribute to juvenile sepsis-associated brain injury.
- MEK blockade exhausts the transcriptional reserve of lipid modifications and sensitizes mutant HRAS to statins
- HDAC inhibition drives NOX5-dependent oxidative stress and sensitizes uveal melanoma cells to SOD1 inhibition
BibTeX
@article{wickert2026decreased,
title = {{Decreased FSP1 expression under chronic hypoxia sensitizes human macrophages towards ferroptosis}},
author = {Anja Wickert and Anna Schwantes and Yara Shadid and Sofie P. Meyer and Bernhard Brüne and Dominik C. Fuhrmann},
journal = {Redox Biology},
year = {2026},
month = oct,
doi = {10.1016/j.redox.2026.104406},
url = {https://doi.org/10.1016/j.redox.2026.104406},
note = {CC BY},
}
RIS
TY - JOUR
TI - Decreased FSP1 expression under chronic hypoxia sensitizes human macrophages towards ferroptosis
AU - Anja Wickert
AU - Anna Schwantes
AU - Yara Shadid
AU - Sofie P. Meyer
AU - Bernhard Brüne
AU - Dominik C. Fuhrmann
PY - 2026
DA - 2026/10/30
JO - Redox Biology
DO - 10.1016/j.redox.2026.104406
UR - https://doi.org/10.1016/j.redox.2026.104406
AB - Ferroptosis, an iron-dependent cell death, emerged as a new therapeutic approach to treat diseases such as cancer or diabetes. Several pathological conditions are characterized by the appearance of chronic hypoxia, which is known to attract immune cells, especially monocytes and macrophages. Therefore, we investigated how chronic hypoxia affects ferroptosis in primary human macrophages and THP-1 cells. Chronic but not acute hypoxia sensitized cells towards ferroptosis, in line with elevated cellular as well as mitochondrial lipid peroxides, and mitochondrial ROS. Time kinetics revealed an earlier increase in lipid peroxidation under chronic hypoxia compared to normoxia, which was followed by mitochondrial lipid peroxidation and mitochondrial ROS. Mechanistically, and in contrast to normoxia and/or acute hypoxia, chronic hypoxia diminished nuclear abundance and activity of the antioxidant transcription factor NRF2. Consequently, NRF2 target gene expression, including ferroptosis suppressor protein 1 (FSP1), decreased. Inhibition or knockdown of FSP1 mimicked the ferroptosis-sensitizing effect of chronic hypoxia. To causatively link decreased NRF2 activity to increased ferroptosis under hypoxia, we inhibited KEAP1, which preserved NRF2 activity, increased FSP1 expression, and decreased ferroptosis. Our data provides novel insights into NRF2 regulation under chronic hypoxia linked to FSP1 expression and ferroptosis sensitivity of primary human macrophages.
SN - 2213-2317
ER -